p.123 抽出テキスト

severe cancer pain. Pain 1997;69:295‒302 19) Hagen NA, Thirlwell M, Eisenhoffer J, et al. Efficacy, safety, and steady‒state pharmacokinetics of once‒a‒day controlled‒release morphine(MS Contin XL)in cancer pain. J Pain Symptom Manage 2005;29:80‒90 20) Homsi J, Walsh D, Lasheen W, et al. A comparative study of 2 sustained‒release morphine preparations for pain in advanced cancer. Am J Hosp Palliat Care 2010;27:99‒105 21) Kerr RO, Tester WJ. A patient preference study comparing two extended‒release morphine sulfate formulations(once‒daily Kadian® versus twice‒daily MS Contin®)for cancer pain. Clinical Drug Investigation 2000;19:25‒32 22) Ferrell B, Wisdom C, Wenzl C, et al. Effects of controlled‒released morphine on quality of life for cancer pain. Oncol Nurs Forum 1989;16:521‒6 23) Hoskin PJ, Poulain P, Hanks GW. Controlled‒release morphine in cancer pain. Is a loading dose required when the formulation is changed? Anaesthesia 1989;44:897‒901 24) Finn JW, Walsh TD, MacDonald N, et al. Placebo‒blinded study of morphine sulfate sustained‒release tablets and immediate‒release morphine sulfate solution in outpatients with chronic pain due to advanced cancer. J Clin Oncol 1993;11:967‒72 25) Arkinstall WW, Goughnour BR, White JA, et al. Control of severe pain with sustained‒release morphine tablets versus oral morphine solution. CMAJ 1989;140:653‒7 26) Gillette JF, Ferme C, Moisy N, et al. Double‒blind crossover clinical and pharmacokinetic comparison of oral morphine syrup and sustained release morphine sulfate capsules in patients with cancer‒related pain. Clinical Drug Investigation 1997;14(Suppl 1):22‒7 27) Hanks GW, Twycross RG, Bliss JM. Controlled release morphine tablets:a double‒blind trial in patients with advanced cancer. Anaesthesia 1987;42:840‒4 28) Ventafridda V, Saita L, Barletta L, et al. Clinical observations on controlled‒release morphine in cancer pain. J Pain Symptom Manage 1989;4:124‒9 29) Walsh TD. Clinical evaluation of slow release morphine tablets. Adv Pain Res Ther 1985;9: 727‒31 30) Walsh TD, MacDonald N, Bruera E, et al. A controlled study of sustained‒release morphine sulfate tablets in chronic pain from advanced cancer. Am J Clin Oncol 1992;15:268‒72 31) Deschamps M, Band PR, Hislop TG, et al. The evaluation of analgesic effects in cancer patients as exemplified by a double‒blind, crossover study of immediate‒release versus controlled‒ release morphine. J Pain Symptom Manage 1992;7:384‒92 32) Thirlwell MP, Sloan PA, Maroun JA, et al. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled‒release morphine tablets in cancer patients. Cancer 1989;63 (Suppl 11):2275‒83 33) Klepstad P, Kaasa S, Jystad A, et al. Immediate‒ or sustained‒release morphine for dose finding during start of morphine to cancer patients:a randomized, double‒blind trial. Pain 2003; 101:193‒8 34) Xu GZ, Cai ZJ, Deng YP, et al. Clinical evaluation of the analgesic effect of sustained release morphine sulfate microgranules in patients with terminal cancer. Clinical Drug Investigation 1997;14(Suppl 1):34‒42 35) Dale O, Piribauer M, Kaasa S, et al. A double‒blind, randomized, crossover comparison between single‒dose and double‒dose immediate‒release oral morphine at bedtime in cancer patients. J Pain Symptom Manage 2009;37:68‒76 36) Cundiff D, McCarthy K, Savarese JJ, et al. Evaluation of a cancer pain model for the testing of long‒acting analgesics. The effect of MS Contin in a double‒blind, randomized crossover design. Cancer 1989;63(Suppl 11):2355‒9 37) Panich A, Charnvej L. Comparison of morphine slow release tablet(MST)and morphine sulphate solution(MSS)in the treatment of cancer pain. J Med Assoc Thai 1993;76:672‒6 38) De Conno F, Ripamonti C, Saita L, et al. Role of rectal route in treating cancer pain:a randomized crossover clinical trial of oral versus rectal morphine administration in opioid‒naive cancer patients with pain. J Clin Oncol 1995;13:1004‒8 39) Harris JT, Suresh Kumar K, Rajagopal MR. Intravenous morphine for rapid control of severe cancer pain. Palliat Med 2003;17:248‒56 40) Vainio A, Tigerstedt I. Opioid treatment for radiating cancer pain:oral administration vs. epidural techniques. Acta Anaesthesiol Scand 1988;32:179‒85 41) Dellemijn PL, Verbiest HB, van Vliet JJ, et al. Medical therapy of malignant nerve pain. A

randomised double‒blind explanatory trial with naproxen versus slow‒release morphine. Eur J Cancer 1994;30A:1244‒50